Technology Niu Technologies Announces Unaudited Second Quarter 2026 Financial Results August 10, 2026
Biotech Oculis Signs Asset Purchase Agreement with Accure Therapeutics for Lead Candidate, Privosegtor, Fortifying Oculis’ Position as an Emerging Leading Neuro-Ophthalmology Company August 10, 2026
Health RadNet Reports Second Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges August 10, 2026